Rzadkie przyczyny owrzodzeń twarzy na przykładzie ziarniniaka Wegenera i piodermii zgorzelinowej

ARTYKUŁ PRZEGLĄDOWY

Rzadkie przyczyny owrzodzeń twarzy na przykładzie ziarniniaka Wegenera i piodermii zgorzelinowej

Karolina Kędzierska 1 , Krzysztof Sindrewicz 2 , Tomasz Smektała 2 , Magda Wiśniewska 1 , Marek Masiuk 3 , Ewelina Staniszewska 2 , Katarzyna Sporniak- Tutak 2 , Edyta Gołembiewska 1 , Kazimierz Ciechanowski 1

1. Department of Nephrology, Transplantology and Internal Medicine, Pomeranian Medical University, Szczecin, Poland
2. Department of Maxillofacial Surgery, Pomeranian Medical University, Szczecin, Poland
3. Department of Pathomorphology, Pomeranian Medical University, Pomeranian Medical University, Szczecin, Poland

Opublikowany: 2016-03-16
DOI: 10.5604/17322693.1197372
GICID: 01.3001.0009.6801
Dostępne wersje językowe: pl en
Wydanie: Postepy Hig Med Dosw 2016; 70 : 210-218

 

Abstrakt

Przypisy

  • 1. Boudny C., Nievergelt H., Braathen L.R., Simon D.: Wegener’sgranulomatosis presenting as pyoderma gangrenosum. J. Dtsch.Dermatol. Ges., 2008; 6: 477-479
    Google Scholar
  • 2. Callen J.P.: Pyoderma gangrenosum. Lancet, 1998; 351: 581-585
    Google Scholar
  • 3. Castillo R.F., Cañadas-De la Fuente G.A., Husein-Elahmed H., Cantero-Hinojosa J.: Pyoderma gangrenosum developing over an arteriovenousfistula scar. Intern. Med. J., 2011; 41: 436-437
    Google Scholar
  • 4. Daoud M.S., Gibson L.E., DeRemee R.A., Specks U., el-Azhary R.A.,Su W.P.: Cutaneous Wegener’s granulomatosis: clinical, histopathologic,and immunopathologic features of thirty patients. J. Am. Acad.Dermatol., 1994; 31: 605-612
    Google Scholar
  • 5. Francès C., Du L.T., Piette J.C., Saada V., Boisnic S., Wechsler B.,Blétry O., Godeau P.: Wegener’s granulomatosis. Dermatologicalmanifestations in 75cases with clinicopathologic correlation. Arch.Dermatol., 1994; 130: 861-867
    Google Scholar
  • 6. Hoffman M.D.: Pyoderma gangrenosum associated with c-ANCA(h-lamp-2). Int. J. Dermatol., 2001; 40: 135-137
    Google Scholar
  • 7. Iwatani H., Uzu T., Kakihara M., Nakayama Y., Kanasaki K., YamatoM., Hirai Y., Umimoto K., Yamauchi A.: A case of Wegener’s granulomatosiswith pulmonary bleeding successfully treated with doublefiltration plasmapheresis (DFPP). Clin. Exp. Nephrol., 2004; 8: 369-374
    Google Scholar
  • 8. Jackson J.M., Callen J.P.: Pyoderma Gangrenosum. Emedicine.http://emedicine.medscape.com/article/1123821-overview(28.01.2016)
    Google Scholar
  • 9. Jacob S.E., Martin L.K., Kerdel F.A.: Cutaneous Wegener’s granulomatosis(malignant pyoderma) in a patient with Crohn’s disease.Int. J. Dermatol., 2003; 42: 896-898
    Google Scholar
  • 10. Jayne D.R., Gaskin G., Rasmussen N., Abramowicz D., FerrarioF.,Guillevin L., Mirapeix E., Savage C.O., Sinico R.A., Stegeman C.A.,Westman K.W., van der Woude F.J., de Lind van Wijngaarden R.A.,Pusey C.D.: European Vasculitis Study Group: Randomized trial ofplasma exchange or high-dosage methylprednisolone as adjunctivetherapy for severe renal vasculitis. J. Am. Soc. Nephrol., 2007;18: 2180-2188
    Google Scholar
  • 11. Jennette J.C., Falk R.J., Andrassy K., Bacon P.A., Churg J., GrossW.L., Hagen E.C., Hoffman G.S., Hunder G.G., Kallenberg C.G., et al.:Nomenclature of systemic vasculitides. Proposal of an internationalconsensus conference. Arthritis Rheum., 1994; 37: 187-192
    Google Scholar
  • 12. Jiménez-Gallo D., Albarrán-Planelles C., Linares-Barrios M.,Rodríguez-Hernández C., Martínez-Rodríguez A., García-MorenoE., Bravo-Monge R.: Pyoderma gangrenosum and Wegener granulomatosis-like syndrome induced by cocaine. Clin. Exp. Dermatol.,2013; 38: 878-882
    Google Scholar
  • 13. Kawakami T., Obara W., Soma Y., Mizoguchi M.: Palisading neutrophilicgranulomatous dermatitis in a Japanese patient with Wegener’sgranulomatosis. J. Dermatol., 2005; 32: 487-492
    Google Scholar
  • 14. Kouba D.J., Mimouni D., Ha C.T., Nousari C.H.: Limited Wegener’sgranulomatosis manifesting as malignant pyoderma with cornealmelt. Int. J. Dermatol., 2003; 42: 902-904
    Google Scholar
  • 15. Kuchel J., Lee S.: Cutaneous Wegener’s granulomatosis: a variantor atypical localized form? Australas. J. Dermatol., 2003; 44: 129-135
    Google Scholar
  • 16. Leavitt R.Y., Fauci A.S., Bloch D.A., Michel B.A., Hunder G.G., ArendW.P., Calabrese L.H., Fries J.F., Lie J.T., Lightfoot R.W. Jr., et al.: TheAmerican College of Rheumatology 1990 criteria for the classificationof Wegener’s granulomatosis. Arthritis Rheum., 1990; 33: 1101-1107
    Google Scholar
  • 17. Le Hello C., Bonte I., Mora J.J., Verneuil L., Noël L.H., Guillevin L.: Pyodermagangrenosum associated with Wegener’s granulomatosis: partialresponse to mycophenolate mofetil. Rheumatology, 2002; 41: 236-237
    Google Scholar
  • 18. Mills B.J.: Wound healing: the evidence for hyperbaric oxygentherapy. Br. J. Nurs., 2012; 21 (Suppl. 20): S28-S34
    Google Scholar
  • 19. Nölle B., Specks U., Lüdemann J., Rohrbach M.S., DeRemee R.A.,Gross W.L.: Anticytoplasmic autoantibodies: their immunodiagnosticvalue in Wegener granulomatosis. Ann. Intern. Med., 1989; 111: 28-40
    Google Scholar
  • 20. Perkins G.D., Moudgil H., Jones R.: Pyoderma gangrenosum.Thorax, 2000; 55: 347
    Google Scholar
  • 21. Powell F.C., Winkelmann R.K.: Malignant pyoderma. Br. J. Dermatol.,1983; 109: 597-603
    Google Scholar
  • 22. Reichrath J., Bens G., Bonowitz A., Tilgen W.: Treatment recommendationsfor pyoderma gangrenosum: an evidence-based reviewof the literature based on more than 350 patients. J. Am. Acad. Dermatol.,2005; 53: 273-283
    Google Scholar
  • 23. Schönermarck U., Lamprecht P., Csernok E., Gross W.L.: Prevalenceand spectrum of rheumatic diseases associated with proteinase3-antineutrophil cytoplasmic antibodies (ANCA) and myeloperoxidase-ANCA. Rheumatology, 2001; 40: 178-184
    Google Scholar
  • 24. Sinovich V., Snow J.: Protracted superficial Wegener’s granulomatosis.Australas. J. Dermatol., 2003; 44: 207-214
    Google Scholar
  • 25. Szõcs H.I., Torma K., Petrovicz E., Hársing J., Fekete G., KárpátiS., Horváth A.: Wegener’s granulomatosis presenting as pyodermagangrenosum. Int. J. Dermatol., 2003; 42: 898-902
    Google Scholar
  • 26. Szpirt W.M., Heaf J.G., Petersen J.: Plasma exchange for inductionand cyclosporine A for maintenance of remission in Wegener’sgranulomatosis – a clinical randomized controlled trial. Nephrol.Dial. Transplant., 2011; 26: 206-213
    Google Scholar
  • 27. Szymańska B., Kawecki M., Knefel G.: Kliniczne aspekty hiperbariitlenowej. Wiad. Lek., 2006; 59: 105-109
    Google Scholar
  • 28. Wollina U.: Clinical management of pyoderma gangrenosum.Am. J. Clin. Dermatol., 2002; 3: 149-158
    Google Scholar
  • 29. Wong Y.W., Lyon C.C., Benbow E.W., Bradley B.L., Beck M.H.:Pyoderma gangrenosum in a thoracotomy wound associated with apulmonary cavitating lesion. Clin. Exp. Dermatol., 2003; 28: 274-276
    Google Scholar
  • 30. Zycinska K., Wardyn K., Zielonka T.M., Nitsch-Osuch A., SmolarczykR.: Cutaneous changes: an initial manifestation of pulmonaryWegener’s granulomatosis. Adv. Exp. Med. Biol., 2013; 755: 307-310
    Google Scholar

Pełna treść artykułu

Przejdź do treści